Showing results (11-20 of 428) with videos related to
Sort By:
Pageof 43
American Family Physician|November 9, 2005
Supporting self-management in patients with chronic illnessMary Thoesen Coleman, Karen S NewtonCNS Drugs|August 19, 2007
Neurogenic actions of atypical antipsychotic drugs and therapeutic implicationsSamuel S Newton, Ronald S DumanAdvanced Drug Delivery Reviews|April 11, 2022
Immunophenotyping: Analytical approaches and role in preclinical development of nanomedicinesHannah S Newton, Marina A DobrovolskaiaAtherosclerosis|October 1, 1995
Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal modelsB R Krause, R S NewtonCurrent Neurovascular Research|September 27, 2005
Regulation of neurogenesis and angiogenesis in depressionSamuel S Newton, Ronald S DumanAtherosclerosis. Supplements|February 8, 2003
HDL therapy for the acute treatment of atherosclerosisRoger S Newton, Brian R KrausePlant Molecular Biology|February 24, 2001
An osmotin-like cryoprotective protein from the bittersweet nightshade Solanum dulcamaraS S Newton, J G DumanExpert Opinion on Drug Discovery|March 15, 2013
Customizing microarrays for neuroscience drug discoveryMatthew J Girgenti, Samuel S NewtonJournal of Lipid Research|August 1, 1985
Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed ratsB R Krause, R S NewtonAtherosclerosis|January 1, 1986
Gemfibrozil increases both apo A-I and apo E concentrations. Comparison to other lipid regulators in cholesterol-fed ratsB R Krause, R S NewtonPageof 43